![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 42, 39012-39020, October 19, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Divisions of The murine sak gene encodes a
putative serine-threonine kinase which is homologous to the members of
the Plk/Polo family. Although Sak protein is presumed to be involved in
cell growth mechanism, efforts have failed to demonstrate its kinase
activity. Little has been, therefore, elucidated how Sak is regulated
and how Sak contributes to cell proliferation. Tec is a cytoplasmic protein-tyrosine kinase (PTK) which becomes activated by the
stimulation of cytokine receptors, lymphocyte surface antigens,
heterotrimeric G protein-linked receptors, and integrins. To clarify
the in vivo function of Tec, we have tried to isolate the
second messengers of Tec by using the yeast two-hybrid screening. One
of such Tec-binding proteins turned out to be Sak. In human kidney 293 cells, Sak became tyrosine-phosphorylated by Tec, and the
serine-threonine kinase activity of Sak was detected only under the
presence of Tec, suggesting Sak to be an effector molecule of Tec. In
addition, Tec activity efficiently protects Sak from the "PEST"
sequence-dependent proteolysis. Internal deletion of the
PEST sequences led to the stabilization of Sak proteins, and expression
of these mutants acted suppressive to cell growth. Our data
collectively supports a novel role of Sak acting in the PTK-mediated
signaling pathway.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB006972.
Sak Serine-Threonine Kinase Acts as an Effector of Tec
Tyrosine Kinase*
§,
,
,
,
**,
**,
**
,
,
**, and
¶¶
Functional Genomics,
Cardiology and ** Hematology, Jichi Medical School,
Kawachi-gun, Tochigi 329-0498, Japan, the ¶ Hematology Branch,
NHLBI, National Institutes of Health, Bethesda, Maryland 20892, and the
§§ Department of Hemopoietic Factors, Institute
of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
*
This work was supported in part by grants-in-aid for
Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture, Japan, and the Japan Intractable Diseases
Research Foundation.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

Supported by the Research Award to Jichi Medical School
Graduate Student.
¶¶
To whom correspondence should be addressed: Div. of
Functional Genomics, Jichi Medical School, 3311-1 Yakushiji,
Kawachi-gun, Tochigi 329-0498, Japan. Tel.: 81-285-58-7449; Fax:
81-285-44-7322; E-mail: hmano@jichi.ac.jp.
This article has been cited by other articles:
![]() |
Y. L. Choi, K. Takeuchi, M. Soda, K. Inamura, Y. Togashi, S. Hatano, M. Enomoto, T. Hamada, H. Haruta, H. Watanabe, et al. Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer Cancer Res., July 1, 2008; 68(13): 4971 - 4976. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Read, P. J. Goodfellow, E. R. Mardis, N. Novak, J. R. Armstrong, and R. L. Cagan A Drosophila Model of Multiple Endocrine Neoplasia Type 2 Genetics, November 1, 2005; 171(3): 1057 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ma, C. L. Nutt, P. Shanehsaz, X. Peng, D. N. Louis, and D. M. Kaetzel Autocrine Platelet-Derived Growth Factor-Dependent Gene Expression in Glioblastoma Cells Is Mediated Largely by Activation of the Transcription Factor Sterol Regulatory Element Binding Protein and Is Associated with Altered Genotype and Patient Survival in Human Brain Tumors Cancer Res., July 1, 2005; 65(13): 5523 - 5534. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |